Science World ReportShire to conduct clinical trials of Vyvanse in preschool-age children with ADHDPharmaceutical Business ReviewShire has agreed to a written request by the US Food and Drug Administration (FDA) to conduct pediatric clinical studies to investigate the potential use of Vyvanse (lisdexamfetamine dimesylate) to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in …Shire okays FDA request to study ADHD drugCNBC.comShire to test ADHD drug on pre-school childrenFinancial TimesUPDATE 1-Shire to test its ADHD drug in 4 to 5-year olds in USReutersWall Street Journal -The Times (subscription)all 34 news articles …Read Full Story
Shire to conduct clinical trials of Vyvanse in preschool-age children with ADHD - Pharmaceutical Business Review
Real Estate of Cebu
